Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro

Osteoarthritis and Cartilage

Volumn 8, Issue 3, 2000, Pages 207-212

  Piperno, M ^a   Reboul, P ^b   Hellio Le Graverand, M P ^a   Peschard, M J ^b   Annefeld, M ^c   Richard, M ^b   Vignon, E ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c Rotta Research Laboratorium   (Italy)

Author keywords

Articular cartilage; Chondrocytes; Collagenase; Glucosamine sulfate; Osteoarthritis; Phospholipase A2; Protein kinase C

Indexed keywords

COLLAGENASE; CYCLIC AMP; GLUCOSAMINE SULFATE; NITRIC OXIDE; PHOSPHOLIPASE A2; PROTEIN KINASE C; PROTEINASE;

ARTICLE; CARTILAGE CELL; CELL ACTIVITY; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0034111377     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1999.0291     Document Type: Article

References (37)

1. Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I. Glucosamine in osteoarthritis of the knee. Osteoarthritis and Cartilage. 2:1994;51-60.
2. Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis and Cartilage. 2:1994;61-70.
3. Rovati LC, Giacovelli G, Annefeld M, Dreiser L, Avouac B. A large randomised, placebo controlled, double-blind study of glucosamine sulfate vs. piroxicam and vs. their association, on the kinetics of the symptomatic effect in knee osteoarthritis. Osteoarthritis and Cartilage. 2:1994;56.
4. Altman RD. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoathritis Research Society. Osteoarthritis and Cartilage. 4:1996;217-243.
5. Dougados M. For the Group for the Respect of Ethics and Excellence in Science. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis. 55:1996;552-557.
6. Reginster JY, Decroix R, Paul I. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large randomized, placebo-controlled double blind prospective trial. Arthritis Rheum. 1999.
7. Senitkar I, Cereda R, Pacini MA, Revel L. Antireactive properties of glucosamine sulfate. Arzneim-Forsch. 41:1991;157-161.
8. Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature. 260:1976;808-809.
9. Dean DD. Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum. 20:1991;2-11.
10. Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 33:1990;1466-1476.
11. Tsuchiya K, Maloney WJ, Vu T, Hoffman AR, Hule P, Sibley R, Schurman DJ, Smith RL. Osteoarthritis: differential expression of matrix metalloproteinase in non-fibrillated and fibrillated cartilage. J Orthop Res. 15:1997;94-100.
12. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg Am. 53:1971;523-527.
13. Algner T, Vornehm SI, Zeidler G, Dudhia J, Von der Mark K, Bayliss MT. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 40:1997;562-569.
14. Martel Pelletier JP, McCollum R, Dibattista J, Faure MP, Chin JA, Fournier S, Sarfati M, Pelletier JP. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum. 35:1992;530-540.
15. Westacott CL, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor-α receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol. 21:1994;1710-1715.
16. Vignon E, Mathieu P, Louisot P, Vilamitjana J, Harmand MF, Richard M. Phospholipase A2 activity in human osteoarthritic cartilage. J Rheumatol. 16:1989;35-38.
17. Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar T, Stuchin S, Abramson SB. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for an inducible 'neuronal-like' nitric oxide synthase. J Exp Med. 182:1995;2097-2102.
18. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxyde inhibits IL-ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis and cartilage. 4:1996;77-84.
19. Vidal Y, Plana RR, Bizzarri D, Rovati AL. Articular cartilage pharmacology. In vitro studies on glucosamine and non steroidal anti-inflammatory drugs. Pharmacol Res Comm. 10:1978;557-569.
20. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis and Cartilage. 6:1998;427-434.
21. 4) on human chondrocyte gene expression. Osteoarthritis and Cartilage. 5:1997;72.
22. Hellio MP, Peschard MJ, Cohen C, Richard M, Vignon E. Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes. Osteoarthritis and Cartilage. 5:1997;121-128.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. The bicinchoninic acid solution for protein determination. Anal biochem. 150:1985;76-85.
24. Vignon E, Mathieu P, Louisot P, Richard M. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum. 34:1991;1332-1335.
25. Hannun YA, Loomis CR, Merrill AH, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem. 261:1986;1260-1269.
26. Steiner AL, Pagliara AS, Chase LR, Kipnis DM. Radioimmunoassay for cyclic nucleotides: adenosine 3′ 5′ monophosphate and guanosine 3′ 5′ monophosphate in mammalian tissues and body fluids. J Biol Chem. 247:1972;1114-1120.
27. Harper JF, Brooker G. Fentomole sensitive radioimmunoassay for cyclic AMP and GM2 after 2-O-acetylation by acetic anhydride in aqueous solution. J Cycl Nucl Res. 1:1975;207-218.
28. Vignon E, Mathieu P, Bejui J, Descotes J, Hartmann D, Patricot LM, Richard M. Study of an inhibitor of plasminogen activator (tranexamic acid) in the treatment of experimental osteoarthritis. J Rheumatol. 27:1991;131-133.
29. Yu LP, Smith GN, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum. 35:1992;1150-1159.
30. Pruzanski W, Bogoch E, Katz A, Wloch M, Stefanski E, Grouix B, Sakotic G, Vadas P. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes. J Rheumatol. 22:1995;2114-2119.
31. Kortekangas P, Aro HT, Nevalainen TJ. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol. 23:1994;68-72.
32. Balblanc JC, Conrozier T, Mathieu P, Tron AM, Broquet P, Piperno M, Richard M, Vignon E. Serum phospholipase A2 activity in osteoarthritis. Rev Rhum Ed Fr. 61:1994;311-317.
33. Schrier DJ, Flory CM, Finkel M, Kuchera SL, Lesh ME, Jacobson PB. The effects of the phospholipase A2 inhibitor manolide on cartilage degradation, stromelysin expression and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1-α in the rabbit. Arthritis Rheum. 39:1996;1291-1299.
34. Richard M, Vignon E, Peschard MJ, Broquet P, Carret JP, Louisot P. Serotonin-stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articular cartilage. Febs Letters. 278:1991;38-40.
35. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxyde mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun. 200:1994;142-148.
36. Arner EC, Pratta MA. Modulation of interleukin-1-induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C. Arthritis Rheum. 34:1991;1006-1013.
37. Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Arzneim-Forsch. 3:1993;538-550.